# Radiopharmaceuticals PLUVICTO / LUTATHERA - Nuclear Med, IND

Canonical: https://abierto.us/opportunities/36c25026n0310

- Solicitation number: 36C25026N0310
- Notice type: Special notice
- Status: Awarded to Novartis Pharmaceuticals Corporation
- Department: Department of Veterans Affairs
- Contracting office: 250-Network Contract Office 10 (36C250)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- County: Morris County (FIPS 34027). https://abierto.us/counties/morris-county-nj-34027
- First posted: January 29, 2026
- Last posted: January 29, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/0d694620a9ef4e129249804d78bde473/view

## Description

Notice of Intent to Sole Source Requirement The Department of Veterans Affairs, VA Healthcare System, Network 10 Contracting Office intends to negotiate a sole source contract for a FDA approved radioactive therapy drug under the authority of GSAR 538.7104-3(b)(1)(ii): Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. The associated NAICS code for this is 325412. The vendor will be Novartis, Route 10, East Hanover, NJ, 07936. Description of services:

**SUPPLY:** This is a new FDA approved radioactive therapy drug. The therapeutic effectiveness of this radioactive drug has changed standard patient care guidelines and now patients diagnosed with prostate cancer are recommended to have Lu177 PLUVICTO as a treatment option. Also needed is the purchase of the Lu177 LUTATHERA. A One Year firm fixed price contract shall be awarded. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement.

It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. It is not a solicitation or request for offers.

## Award on USAspending

- Recipient: Novartis Pharmaceuticals Corporation (UEI NG61ZA8TADW3)
- Contract: 36C25026N0310 under 36F79720D0180, delivery order
- Obligated: $2,423,132.82
- Competition: Full and Open Competition, 1 offers received
- Link: solicitation number 36C25026N0310 was reused as the contract number; same awarding office 36C250 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_36C25026N0310_3600_36F79720D0180_3600/


## Publications

- January 29, 2026: Special notice, due January 30, 2026 at 3:00 PM EST. Notice 0d694620a9ef4e129249804d78bde473. https://sam.gov/workspace/contract/opp/0d694620a9ef4e129249804d78bde473/view

## Points of contact

- Aroosa Shah (Centeva), eCMS Consultant, Aroosa.Shah@va.gov, 937-503-4194

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/36c25026n0310.